136 - GETTING TO THE HEART OF BECOMING A SUCCESSFUL CARDIOVASCULAR RESEARCHER

Thursday, October 24, 2024

11:00 AM – 12:00 PM PT

Room: 215-216

Learn from some of Canada’s leading clinician-scientists and data scientists on what it takes to become a successful cardiovascular researcher.
Explore the multifaceted journey of becoming a clinician-scientist. We'll delve into the pros and cons of pursuing post-graduate degrees, discussing their worth and optimal timing during one's career trajectory. Additionally, we'll tackle the delicate balance between a clinical and academic career, addressing strategies for managing professional responsibilities while maintaining a fulfilling personal life. Don't miss this opportunity to gain valuable perspectives and strategies in the journey to become a clinician scientist!

Learning Objectives:

At the end of this session participants will be able to:

to discuss the various career paths and trajectories to becoming clinician-scientists in the cardiovascular sciences;
to outline techniques and strategies for work-life balance and finding a balance between clinical and scientific domains through the various stages of training; and
to highlight methods in which to effectively collaborate with data analysts, statisticians, and other allied health team members to develop an effective clinical research program

Disclosure(s):

Braeden Hill, BHSc: No financial relationships to disclose

Chandu Sadasivan, MD: No financial relationships to disclose

Jeff Yim, MD: No financial relationships to disclose

Nicholas Grubic, MSc: No financial relationships to disclose

Andrew D. Krahn, MD: Medtronic: Consultant/Advisory Board (Ongoing); Tenaya Pharmaceuticals: Consultant/Advisory Board (Ongoing)

Guillaume Marquis-Gravel, MD, MSc: Bayer: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, December 7, 2021), Speaker/Honoraria (Terminated, December 7, 2021); Boston Scientific: Consultant/Advisory Board (Terminated, May 12, 2022); CSI: Speaker/Honoraria (Terminated, April 26, 2022); HLS Therapeutics: Consultant/Advisory Board (Terminated, April 20, 2023); JAMP Pharma: Consultant/Advisory Board (Terminated, April 16, 2024), Speaker/Honoraria (Terminated, April 16, 2024); KYE: Consultant/Advisory Board (Terminated, May 11, 2022), Speaker/Honoraria (Terminated, May 11, 2022); Novartis: Consultant/Advisory Board (Terminated, September 18, 2023), Consultant/Advisory Board (Terminated, September 18, 2023), Speaker/Honoraria (Terminated, September 18, 2023); Pharmascience: Speaker/Honoraria (Terminated, April 14, 2022)

Emilie P. Belley-Cote, MD: Abbott: unrestricted grant (Ongoing); Bayer: Unrestricted investigator grant (Terminated, December 31, 2023); BMS-Pfizer: unrestricted grant (Terminated, December 31, 2022); Roche Diagnositcs: unrestricted grant (Terminated, December 31, 2023); Trimedic Therapeutics: consulting (Terminated, February 13, 2023)

Co-Chair(s)

Edward Cui, BHSc

Medical Student
Queen's University
Braeden Hill, BHSc

MD/PhD Student
University of Toronto
University of Toronto
Chandu Sadasivan, MD

Internal Medicine Resident
University of Alberta
Jeff Yim, MD

Cardiology fellow
CSE

Presenter(s)

Nicholas Grubic, MSc (he/him/his)

Doctoral Student (Epidemiology)
University of Toronto
Andrew D. Krahn, MD (he/him/his)

Professor of Medicine
University of British Columbia
University of British Columbia
Guillaume Marquis-Gravel, MD, MSc

Interventional Cardiologist, Assistant Professor
Montreal Heart Institute
Montreal Heart Institute
Emilie P. Belley-Cote, MD

Associate Professor
McMaster University
McMaster Unviersity

Planning Committee Member(s)

Edward Cui, BHSc

Medical Student
Queen's University
Braeden Hill, BHSc

MD/PhD Student
University of Toronto
University of Toronto
Chandu Sadasivan, MD

Internal Medicine Resident
University of Alberta
Jeff Yim, MD

Cardiology fellow
CSE